BioCentury
ARTICLE | Clinical News

NGAL Test: Clinical trial completed enrollment

April 20, 2015 7:00 AM UTC

BioPorto completed enrollment of 250 ICU patients in a blinded, U.S. clinical trial comparing its NGAL Test vs. clinical diagnosis of AKI as determined by Kidney Disease Improving Global Outcomes (KDI...